SCHEMBL25849271

SCHEMBL25849271

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc4c(c3)sc3cccc(-c5nc(-c6ccccc6)c6oc7ccccc7c6n5)c34)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.35
POLB P06746 3/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 11/20 0.34
KMT2A Q03164 7/20 0.34
LMNA P02545 5/20 0.34
TSHR P16473 4/20 0.34
HTT P42858 1/20 0.34
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
MEN1 O00255 6/20 0.33
NPSR1 Q6W5P4 3/20 0.33
GAA P10253 2/20 0.33
HSD17B10 Q99714 3/20 0.32
USP2 O75604 1/20 0.32
MAPK1 P28482 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25850482 0.94 ALDH1A1 (0.36) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL22195847 0.88 MAPT (0.39) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL22330088 0.88 MAPT (0.39) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL23686303 0.88 MAPT (0.39) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL25016582 0.88 MAPT (0.39) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL25017038 0.88 MAPT (0.39) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL22330261 0.88 MAPT (0.39) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL25016467 0.87 MAPT (0.40) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL25018031 0.87 MAPT (0.40) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL22329745 0.87 MAPT (0.40) ALDH1A1POLBKDM4EHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4206198-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 ALDH1A1 544/4885POLB 1974/4885KDM4E 2882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.